These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 386519)

  • 41. Platelet and fibrinogen kinetic evaluation of thrombogenesis.
    Harker LA
    Scand J Haematol Suppl; 1979; 34():31-51. PubMed ID: 384506
    [No Abstract]   [Full Text] [Related]  

  • 42. [Drug therapy of vasculitis with prostaglandins].
    Makino S
    Nihon Rinsho; 1985 Oct; 43(10):2200-5. PubMed ID: 3912548
    [No Abstract]   [Full Text] [Related]  

  • 43. Platelet aggregation by Thrombofax.
    de Gaetano G; Vermylen J; Verstraete M
    Acta Univ Carol Med Monogr; 1972; 53():391-8. PubMed ID: 4670744
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect of prostacyclin on platelet-activating factor induced rabbit and platelet aggregation.
    Bussolino F; Camussi G
    Prostaglandins; 1980 Nov; 20(5):781-91. PubMed ID: 6258196
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Molecular action of drugs affecting platelet functions (author's transl)].
    Verstraete M
    Rev Med Brux; 1981 Mar; 2(3):301-8. PubMed ID: 6262895
    [No Abstract]   [Full Text] [Related]  

  • 46. Mode of action of dipyridamole on human platelets.
    Best LC; McGuire MB; Jones PB; Holland TK; Martin TJ; Preston FE; Segal DS; Russell RG
    Thromb Res; 1979; 16(3-4):367-79. PubMed ID: 229583
    [No Abstract]   [Full Text] [Related]  

  • 47. Status of antiplatelet drugs in coronary heart disease.
    Mehta J; Mehta P
    JAMA; 1979 Jun; 241(24):2649-51. PubMed ID: 439365
    [No Abstract]   [Full Text] [Related]  

  • 48. Prostaglandins as inhibitors of human platelet aggregation.
    Di Minno G; Silver MJ; de Gaetano G
    Br J Haematol; 1979 Dec; 43(4):637-47. PubMed ID: 393296
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prostacyclin (PGI2) inhibits the development in human platelets of ADP and arachidonic acid-induced shape change and procoagulant activity.
    Ehrman ML; Jaffe EA
    Prostaglandins; 1980 Dec; 20(6):1103-16. PubMed ID: 7010448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of 6-[p-(4-phenylacetylpiperazin-1-yl)phenyl]-4,5-dihydro-3(2H)pyridazinone (CCI 17810) and aspirin on platelet aggregation and adhesiveness.
    Griffett EM; Kinnon SM; Kumar A; Lecker D; Smith GM; Tomich EG
    Br J Pharmacol; 1981 Apr; 72(4):697-705. PubMed ID: 7284687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Platelet accumulation on collagen: drugs which inhibit arachidonic acid metabolism and affect intracellular cyclic AMP levels.
    Adams GA; Feuerstein IA
    Thromb Haemost; 1984 Aug; 52(1):45-9. PubMed ID: 6093281
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Arachidonic acid-induced human platelet aggregation and prostaglandin formation.
    Silver MJ; Smith JB; Ingerman C; Kocsis JJ
    Prostaglandins; 1973 Dec; 4(6):863-75. PubMed ID: 4205973
    [No Abstract]   [Full Text] [Related]  

  • 53. Dihomo-gamma-linolenate suppresses platelet aggregation when administered in vitro or in vivo.
    Willis AL; Comai K; Kuhn DC; Paulsrud J
    Prostaglandins; 1974 Dec; 8(6):509-19. PubMed ID: 4462154
    [No Abstract]   [Full Text] [Related]  

  • 54. Modulation of the inhibitory action of prostaglandin E1 on platelet aggregation in rats: a study with ticlopidine, aspirin, dipyridamole and sulfinpyrazone.
    Tuong CC; Ferrand C; Aubert D; Loubrie JC; Tuong A
    Biochem Pharmacol; 1982 Mar; 31(6):1147-50. PubMed ID: 7200772
    [No Abstract]   [Full Text] [Related]  

  • 55. Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors.
    Rajtar G; Cerletti C; Castagnoli MN; Bertelé V; de Gaetano G
    Biochem Pharmacol; 1985 Feb; 34(3):307-10. PubMed ID: 3918536
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aspirin and dazoxiben as inhibitors of platelet behaviour: modification of their effects by agents that alter cAMP production.
    Sills T; Cowley AJ; Heptinstall S
    Thromb Res; 1986 Apr; 42(1):91-8. PubMed ID: 3010495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ex vivo and in vivo evaluation of drugs that inhibit platelet function.
    Hanson SR; Harker LA
    Ann N Y Acad Sci; 1983; 416():642-50. PubMed ID: 6587821
    [No Abstract]   [Full Text] [Related]  

  • 58. The role of platelets in the genesis of ischemia.
    Colman RW
    Ann N Y Acad Sci; 1982; 382():190-203. PubMed ID: 6282171
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of acetylsalicylic acid and dipyridamole on platelet survival and aggregation in patients with atherosclerosis obliterans.
    Abrahamsen AF; Eika C; Godal HC; Lorentsen E
    Scand J Haematol; 1974; 13(4):241-5. PubMed ID: 4614427
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmacological investigation of substances affecting platelet function.
    Smith GM
    Acta Cardiol; 1974; Suppl 19():95-102. PubMed ID: 4548299
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.